Kera Capital Partners Inc. Purchases New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

Kera Capital Partners Inc. bought a new position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 572 shares of the healthcare conglomerate’s stock, valued at approximately $289,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Pacer Advisors Inc. grew its position in shares of UnitedHealth Group by 5.7% during the 2nd quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate’s stock valued at $33,540,000 after acquiring an additional 3,525 shares during the period. Garden State Investment Advisory Services LLC increased its position in UnitedHealth Group by 13.5% in the second quarter. Garden State Investment Advisory Services LLC now owns 1,049 shares of the healthcare conglomerate’s stock worth $536,000 after buying an additional 125 shares during the last quarter. Columbus Hill Capital Management L.P. bought a new position in shares of UnitedHealth Group during the 2nd quarter worth $14,789,000. Summit Trail Advisors LLC raised its stake in UnitedHealth Group by 33.3% in the 2nd quarter. Summit Trail Advisors LLC now owns 12,008 shares of the healthcare conglomerate’s stock valued at $6,115,000 after acquiring an additional 2,999 shares during the period. Finally, Transatlantique Private Wealth LLC boosted its position in UnitedHealth Group by 9.9% during the second quarter. Transatlantique Private Wealth LLC now owns 2,594 shares of the healthcare conglomerate’s stock worth $1,291,000 after purchasing an additional 234 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of several analyst reports. Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. UBS Group dropped their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday. Truist Financial decreased their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday. Two investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $627.74.

Check Out Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $510.03 on Friday. The company’s fifty day moving average is $549.37 and its 200 day moving average is $562.73. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The stock has a market cap of $469.37 billion, a PE ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the company earned $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.